SCHEMBL4661726

SCHEMBL4661726

O=C=C1C=CC=CN1.[N]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL730714 0.97 — —
SCHEMBL11134192 0.95 — —
SCHEMBL30940538 0.95 — —
Hydrochloric Acid SCHEMBL9393513 0.95 — —
Water SCHEMBL27523845 0.95 — —
SCHEMBL28174902 0.78 NPC1 (0.32) —
SCHEMBL27671880 0.72 — —
SCHEMBL28175602 0.72 — —
SCHEMBL15286437 0.67 — —
SCHEMBL30593066 0.63 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100588398-C Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for the treatment of central nervous system disorders POLIFARMA SPA 2010-02-10 — — CN disclosed
EP-1501503-B1 SUBSTANTIALLY PURE SOLID FORM OF THE ENOL TAUTOMER OF 3-INDOLYPYRUVIC ACID FOR USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISTURBANCES POLIFARMA SPA (IT) 2008-12-24 — — EP disclosed
US-20050208125-A1 Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatmetn of central nervous system disturbances POLIFARMA S.P.A. (IT) 2005-09-22 — — US disclosed
CN-1652773-A Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disorders POLIFARMA SPA (IT) 2005-08-10 — — CN disclosed
EP-1501503-A1 SUBSTANTIALLY PURE SOLID FORM OF THE ENOL TAUTOMER OF 3-INDOLYPYRUVIC ACID FOR USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISTURBANCES POLIFARMA S.p.A. (IT) 2005-02-02 — — EP disclosed
WO-2003094914-A1 SUBSTANTIALLY PURE SOLID FORM OF THE ENOL TAUTOMER OF 3-INDOLYLPYRUVIC ACID FOR USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISTURBANCES POLIFARMA S.P.A. (IT) 2003-11-20 — — WO disclosed
Send feedback